Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)

NCT02367040 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

458

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma,Non-Hodgkin

Interventions

DRUG: Copanlisib (Aliqopa, BAY80-6946)
DRUG: Placebo
DRUG: Rituximab

Sponsor

Bayer